CY1107455T1 - Συνθεση και μεθοδος για την προκληση αποπτωσης σε καρκινικα κυτταρα του προστατη - Google Patents

Συνθεση και μεθοδος για την προκληση αποπτωσης σε καρκινικα κυτταρα του προστατη

Info

Publication number
CY1107455T1
CY1107455T1 CY20051100946T CY051100946T CY1107455T1 CY 1107455 T1 CY1107455 T1 CY 1107455T1 CY 20051100946 T CY20051100946 T CY 20051100946T CY 051100946 T CY051100946 T CY 051100946T CY 1107455 T1 CY1107455 T1 CY 1107455T1
Authority
CY
Cyprus
Prior art keywords
protection
composition
cancer cells
animal
dna
Prior art date
Application number
CY20051100946T
Other languages
English (en)
Inventor
Nigel C Phillips
Mario C Filion
Stéphanie READER
Original Assignee
Bioniche Life Sciences Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioniche Life Sciences Inc. filed Critical Bioniche Life Sciences Inc.
Publication of CY1107455T1 publication Critical patent/CY1107455T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Μέθοδος για τη θεραπεία του καρκίνου του προστάτη σε ένα πειραματόζωο, όπου χορηγείται στο πειραματόζωο που χρειάζεται μια τέτοια θεραπεία μια σύνθεση που περιέχει DNA Mycobacterium phlei (Μ. phlei) (M-DNA) και M-DNA διατηρούμενο και συμπλοκοποιημένο επί του κυτταρικού τοιχώματος Μ. phlei (MCC) σε ποσότητα αποτελεσματική για να έχουμε αντινεοπλασματικό αποτέλεσμα επί των καρκινικών κυττάρων στον προστάτη του πειραματoζώου.
CY20051100946T 1999-04-01 2005-08-03 Συνθεση και μεθοδος για την προκληση αποπτωσης σε καρκινικα κυτταρα του προστατη CY1107455T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12745199P 1999-04-01 1999-04-01
EP00912310A EP1165106B8 (en) 1999-04-01 2000-03-30 Composition and method for inducing apoptosis in prostate cancer cells by m-dna and mcc

Publications (1)

Publication Number Publication Date
CY1107455T1 true CY1107455T1 (el) 2012-12-19

Family

ID=22430191

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20051100946T CY1107455T1 (el) 1999-04-01 2005-08-03 Συνθεση και μεθοδος για την προκληση αποπτωσης σε καρκινικα κυτταρα του προστατη

Country Status (10)

Country Link
EP (1) EP1165106B8 (el)
JP (1) JP2002541114A (el)
AT (1) ATE296106T1 (el)
AU (1) AU780909B2 (el)
CA (1) CA2366090C (el)
CY (1) CY1107455T1 (el)
DE (1) DE60020352T2 (el)
ES (1) ES2238996T3 (el)
PT (1) PT1165106E (el)
WO (1) WO2000059518A2 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000033879A1 (en) * 1998-12-04 2000-06-15 Bioniche Life Sciences Inc. Method for the treatment of inflammation
US20030044352A1 (en) * 2001-04-24 2003-03-06 Phillips Nigel C. Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU736450B2 (en) * 1997-08-05 2001-07-26 Bioniche Urology Ip Inc. Composition and method for regulating cell proliferation and cell death

Also Published As

Publication number Publication date
EP1165106B8 (en) 2005-07-27
JP2002541114A (ja) 2002-12-03
EP1165106A2 (en) 2002-01-02
WO2000059518A2 (en) 2000-10-12
DE60020352T2 (de) 2005-10-20
AU3413500A (en) 2000-10-23
DE60020352D1 (de) 2005-06-30
AU780909B2 (en) 2005-04-21
EP1165106B1 (en) 2005-05-25
ES2238996T3 (es) 2005-09-16
CA2366090A1 (en) 2000-10-12
PT1165106E (pt) 2005-10-31
ATE296106T1 (de) 2005-06-15
CA2366090C (en) 2011-05-24
WO2000059518A3 (en) 2001-02-01

Similar Documents

Publication Publication Date Title
MY121548A (en) Compounds and methods for the treatment of cancer
DK0762898T3 (da) Cyclodextrinsystem til levering af oligonukleotider til celler
KR960704582A (ko) 텍사피린을 사용하는 방사선 감작방법(Radiation sentization using texaphyrins)
ATE324888T1 (de) Krebstherapie
WO2004064727A3 (en) Method of cancer treatment using hdac inhibitors
ID26620A (id) Penghambatan kinase raf yang menggunakan urea-urea heterosiklik yang disubstitusi
CA2534816A1 (en) Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
DE60128551D1 (de) Geladene verbindungen mit einer nukleinsäure-bindenden einheit sowie deren verwendungen
PT781092E (pt) Metodo de sensibilizacao de celulas tumorais utilizando adenovirus e1a
RS20050375A (en) 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
Lansdown et al. Experimental observations in the rat on the influence of cadmium on skin wound repair
Chapman et al. Radiosensitization of Mammalian Cells by p-Nitroacetophenone: II. Effectiveness of Analogues
RU96102402A (ru) Композиция для фотодинамического повреждения клеток-мишеней и способ фотодинамического повреждения клеток-мишеней
EA200300934A1 (ru) Агенты и способы, предназначенные для лечения опухолевых заболеваний
CY1107455T1 (el) Συνθεση και μεθοδος για την προκληση αποπτωσης σε καρκινικα κυτταρα του προστατη
PL374675A1 (en) Use of urease for inhibiting cancer cell growth
PT768886E (pt) Efeitos de revestimento endotelial e tratamento de desordens vasospasticas
ATE307797T1 (de) Aktivierte iod-verbindungen zur behandlung von krebs und aids
DK1509523T3 (da) Triazaspiro-forbindelser anvendelige for at behandle eller forhindre smerte
ATE290390T1 (de) Behandlung des harnblasenkrebses durch mycobacterium phlei zellwand
DE69919386D1 (de) Zusammensetzung zur behandlung von entzündungen
Mikhailov et al. Iron (II)-mimosine catalyzed cleavage of DNA
KR870007191A (ko) 유기백금착물 및 이를 사용한 종양 치료방법
Machado Cost effectiveness of the public provision of substance abuse treatment in Maine
Heikkila Studies on the mode of action of 6-hydroxydopamine and related neurotoxins